In a retrospective study evaluating circulating fatty acid synthase (cFAS) as a biomarker for peripheral artery disease (PAD) ...

Solaris Endovascular announced 12-month results from the Solaris SX iliac postmarket clinical follow-up study of the ...

Angiolutions announced that the first patient has been treated in a first-in-human (FIH) study evaluating the safety and ...

Bentley InnoMed GmbH, which is headquartered in Hechingen, Germany, announced the first-in-human use of the company’s BeG ...

Rampart IC, a developer of radiation shielding for interventional suites, announced new data on the reduction in radiation ...

Penumbra Inc. announced it has secured CE Mark approval for its Lightning Bolt 12 and Lightning Bolt 6X with Trax. These next-g ...

Akura Medical, a Shifamed portfolio company focused on venous thromboembolism care, announced it has secured a $53 million firs ...

Royal Philips announced the expanded commercial availability of its LumiGuide device guidance across Europe and the United Stat ...

Okami Medical, Inc., a developer of vascular embolization solutions, announced that Drew Hykes was appointed President and ...

Pathfinder Medical, a United Kingdom-based developer of minimally invasive vascular access technologies, announced the appoint ...